UY35381A - Pirrolotriazinas como inhibidores del canal del ion potasio - Google Patents
Pirrolotriazinas como inhibidores del canal del ion potasioInfo
- Publication number
- UY35381A UY35381A UY0001035381A UY35381A UY35381A UY 35381 A UY35381 A UY 35381A UY 0001035381 A UY0001035381 A UY 0001035381A UY 35381 A UY35381 A UY 35381A UY 35381 A UY35381 A UY 35381A
- Authority
- UY
- Uruguay
- Prior art keywords
- inhibitors
- pirrolotriazinas
- ion channel
- potassium ion
- function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un compuesto de la Fórmula I en donde A, R1, R3 y R24 se describen en la presente. Los compuestos son útiles como inhibidores de la función del cana l de potasio y para el tratamiento de la arritmia, manteniendo el ritmo sinusal normal, de los trastornos asociados a IKur- y de otros trastornos me diados por la función del canal iónico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361775731P | 2013-03-11 | 2013-03-11 | |
US14/200,055 US9050345B2 (en) | 2013-03-11 | 2014-03-07 | Pyrrolotriazines as potassium ion channel inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UY35381A true UY35381A (es) | 2014-09-30 |
Family
ID=51488539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001035381A UY35381A (es) | 2013-03-11 | 2014-03-11 | Pirrolotriazinas como inhibidores del canal del ion potasio |
Country Status (8)
Country | Link |
---|---|
US (1) | US9050345B2 (es) |
EP (1) | EP2970296B1 (es) |
JP (1) | JP6427551B2 (es) |
CN (1) | CN105008367B (es) |
AR (1) | AR095208A1 (es) |
TW (1) | TW201444847A (es) |
UY (1) | UY35381A (es) |
WO (1) | WO2014143610A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ703632A (en) * | 2012-06-11 | 2016-01-29 | Bristol Myers Squibb Co | Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide |
JP6395798B2 (ja) * | 2013-03-11 | 2018-09-26 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | カリウムイオンチャネル阻害剤としてのピロロトリアジン |
ES2616026T3 (es) | 2013-03-11 | 2017-06-09 | Bristol-Myers Squibb Company | Pirrolopiridazinas como inhibidores de canales de iones potasio |
WO2014143609A1 (en) | 2013-03-11 | 2014-09-18 | Bristol-Myers Squibb Company | Isoquinolines as potassium ion channel inhibitors |
WO2017004134A1 (en) * | 2015-06-29 | 2017-01-05 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
WO2017040448A1 (en) * | 2015-08-31 | 2017-03-09 | Bristol-Myers Squibb Company | Tgf beta receptor antagonists |
CN105111154A (zh) * | 2015-09-15 | 2015-12-02 | 上海瑞博化学有限公司 | 一种5-氨基吡嗪-2-甲酸合成新工艺 |
SG11201804901WA (en) | 2015-12-22 | 2018-07-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
EP3436461B1 (en) | 2016-03-28 | 2023-11-01 | Incyte Corporation | Pyrrolotriazine compounds as tam inhibitors |
CA3021185C (en) * | 2016-04-28 | 2024-06-04 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
US11382881B2 (en) | 2017-05-05 | 2022-07-12 | Nino Sorgente | Methods and compositions for diagnosing and treating glaucoma |
AU2018261756B2 (en) | 2017-05-05 | 2022-01-20 | Nino Sorgente | Methods and compositions for improving eye health |
CA3066939A1 (en) | 2017-06-21 | 2018-12-27 | SHY Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
CN111825675B (zh) * | 2019-04-15 | 2023-08-01 | 武汉朗来科技发展有限公司 | Rock抑制剂及其制备方法和用途 |
JP2023551385A (ja) * | 2020-11-10 | 2023-12-08 | フォグホーン セラピューティクス インコーポレイテッド | 化合物及びその使用 |
CN116063183B (zh) * | 2023-01-28 | 2023-06-27 | 山东国邦药业有限公司 | 一种环丙胺的合成方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
TW536540B (en) | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
ES2318899T3 (es) | 1998-07-06 | 2009-05-01 | Bristol-Myers Squibb Company | Bifenil sulfonamidas como antagonistas duales de los receptores de angiotensina y endotelina. |
WO2000071129A1 (en) * | 1999-05-21 | 2000-11-30 | Bristol-Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
EP1363910B1 (en) | 2000-11-17 | 2006-03-01 | Bristol-Myers Squibb Company | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
US6867300B2 (en) | 2000-11-17 | 2005-03-15 | Bristol-Myers Squibb Company | Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
TWI329112B (en) | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
EP1543009A4 (en) | 2002-08-02 | 2007-08-08 | Bristol Myers Squibb Co | Pyrrolotriazine KINASE INHIBITORS |
TW200420565A (en) * | 2002-12-13 | 2004-10-16 | Bristol Myers Squibb Co | C-6 modified indazolylpyrrolotriazines |
EP1590335A4 (en) | 2003-02-05 | 2006-03-08 | Bristol Myers Squibb Co | PROCESS FOR THE PRODUCTION OF PYRROLOTRIAZINKINASE INHIBITORS |
US7504521B2 (en) | 2004-08-05 | 2009-03-17 | Bristol-Myers Squibb Co. | Methods for the preparation of pyrrolotriazine compounds |
AP2007003923A0 (en) | 2004-09-30 | 2007-02-28 | Tibotec Pharm Ltd | Hcv inhibiting bi-cyclic pyrimidines |
EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
MX2008011136A (es) | 2006-03-07 | 2008-09-08 | Squibb Bristol Myers Co | Compuestos de profamarco de pirrolotriazina anilina utiles como inhibidores de cinasa. |
US20080064718A1 (en) | 2006-03-22 | 2008-03-13 | Saavedra Oscar M | Inhibitors of protein tyrosine kinase activity |
DK2041138T3 (da) * | 2006-07-07 | 2014-08-11 | Bristol Myers Squibb Co | Pyrroltriazinkinase-inhibitorer |
US7531539B2 (en) | 2006-08-09 | 2009-05-12 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
WO2008057402A2 (en) | 2006-11-02 | 2008-05-15 | Cytovia, Inc. | N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof |
EP2134716A1 (en) | 2007-04-18 | 2009-12-23 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
JP5463287B2 (ja) * | 2007-08-17 | 2014-04-09 | アイカジェン, インコーポレイテッド | カリウムチャネル調節物質としての複素環 |
DE102007051762A1 (de) * | 2007-10-30 | 2009-05-07 | Bayer Healthcare Ag | Substituierte Pyrrolotriazine und ihre Verwendung |
JP2011513419A (ja) | 2008-03-06 | 2011-04-28 | ブリストル−マイヤーズ スクイブ カンパニー | ピロロトリアジンキナーゼ阻害剤 |
US20110269740A1 (en) | 2008-07-02 | 2011-11-03 | Ambit Biosciences Corporation | Jak kinase modulating compounds and methods of use thereof |
JP5592890B2 (ja) * | 2008-10-08 | 2014-09-17 | ブリストル−マイヤーズ スクイブ カンパニー | ピロロトリアジンキナーゼ阻害剤 |
US8476282B2 (en) | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
WO2011018894A1 (en) * | 2009-08-10 | 2011-02-17 | Raqualia Pharma Inc. | Pyrrolopyrimidine derivatives as potassium channel modulators |
WO2011028741A1 (en) * | 2009-09-03 | 2011-03-10 | Bristol-Myers Squibb Company | Quinazolines as potassium ion channel inhibitors |
US20120077814A1 (en) | 2010-09-10 | 2012-03-29 | Zhong Wang | Sulfonamide, sulfamate, and sulfamothioate derivatives |
JO3003B1 (ar) | 2011-01-14 | 2016-09-05 | Lilly Co Eli | مركب أيميدازو [4، 5 -c ] كينولين-2- واحد واستخدامه كمثبط كيناز PI3/mtor |
CN103373996A (zh) | 2012-04-20 | 2013-10-30 | 山东亨利医药科技有限责任公司 | 作为crth2受体拮抗剂的二并环衍生物 |
NZ703632A (en) * | 2012-06-11 | 2016-01-29 | Bristol Myers Squibb Co | Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide |
-
2014
- 2014-03-07 US US14/200,055 patent/US9050345B2/en active Active
- 2014-03-10 AR ARP140100817A patent/AR095208A1/es unknown
- 2014-03-10 EP EP14713005.8A patent/EP2970296B1/en active Active
- 2014-03-10 JP JP2016500933A patent/JP6427551B2/ja active Active
- 2014-03-10 CN CN201480013619.4A patent/CN105008367B/zh active Active
- 2014-03-10 WO PCT/US2014/022265 patent/WO2014143610A1/en active Application Filing
- 2014-03-10 TW TW103108204A patent/TW201444847A/zh unknown
- 2014-03-11 UY UY0001035381A patent/UY35381A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014143610A1 (en) | 2014-09-18 |
JP6427551B2 (ja) | 2018-11-21 |
US20140256719A1 (en) | 2014-09-11 |
CN105008367A (zh) | 2015-10-28 |
EP2970296B1 (en) | 2016-12-21 |
US9050345B2 (en) | 2015-06-09 |
JP2016512505A (ja) | 2016-04-28 |
TW201444847A (zh) | 2014-12-01 |
EP2970296A1 (en) | 2016-01-20 |
CN105008367B (zh) | 2017-08-29 |
AR095208A1 (es) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY35381A (es) | Pirrolotriazinas como inhibidores del canal del ion potasio | |
CL2019001709A1 (es) | Derivados pirazol como inhibidores de malt1. | |
CO6511220A2 (es) | Quinazolinas como inhibidores de los canales iónicos de potasio | |
DOP2017000149A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
GT201500348A (es) | Compuestos de pirimidinodiona contra estados cardíacos | |
CU24408B1 (es) | Compuestos de dihidroisoquinolinona sustituida | |
UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
UY34750A (es) | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. | |
CU24414B1 (es) | Lactamas n-(heteroarilo sustituido) fusionadas útiles en el tratamiento del crecimiento celular anormal | |
CU20170056A7 (es) | Métodos para tratar infecciones por el virus filoviridae | |
UY34648A (es) | Amidas como inhibidores de pim | |
NI201500112A (es) | Compuestos de azabencimidazol como inhibidores de isozimas pde4 para el tratamiento del snc y otros trastornos. | |
CR20150067A (es) | Pirazoles sustituidos como bloqueadores del canal de calcio tipo n | |
UY35630A (es) | Carboxamidas primarias como inhibidores de btk | |
UY33943A (es) | Derivados espirocíclicos de isoxazolina como agentes antiparasitarios. | |
CR20120448A (es) | Compuesto heterocíclico | |
CL2017001511A1 (es) | Derivados de piperidina como inhibidores de hdac1/2. | |
CL2017000818A1 (es) | Derivativos de benzotiofenil substituidos como agonistas gpr40 para el tratamiento de diabetes tipo ii | |
UY37774A (es) | Compuestos 5-cianoindol sustituidos y usos de los mismos | |
CL2018002583A1 (es) | Derivado de morfolina | |
CR20150070A (es) | Pirrolopirazoles como bloqueadores del canal de calcio tipo n | |
BR112017009289A2 (pt) | métodos de administrar composições de amantadina | |
CL2016001623A1 (es) | Compuestos de benzamida y nicotinamida y métodos para usar los mismos. | |
BR112015029399A2 (pt) | produção em etapa única de uma composição de polipropileno | |
UY34612A (es) | ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?. |